Related Experiment Video
Updated: Feb 21, 2026
13:00
A Rapid High-throughput Method for Mapping Ribonucleoproteins RNPs on Human pre-mRNA
Published on: December 2, 2009
12.3K
RNA splicing process analysis for identifying antisense oligonucleotide inhibitors with padlock probe-based
Xiaojun Ren1,2, Ruijie Deng2, Lida Wang2
1School of Chemistry and Chemical Engineering , Beijing Institute of Technology , Beijing 100081 , China.
Chemical Science
|October 10, 2017
Summary
Antisense oligonucleotides (ASOs) modulate RNA splicing. A new assay distinguishes how 5'-ASOs inhibit the first splicing step and 3'-ASOs inhibit the second, aiding therapeutic development.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- RNA splicing is crucial for gene expression, with errors linked to genetic diseases.
- Antisense oligonucleotides (ASOs) are tools for gene control via RNA splicing modulation.
- Current methods lack sensitivity to analyze individual RNA splicing steps, obscuring ASO mechanisms.
Purpose of the Study:
- To develop a sensitive assay for quantifying RNA splicing steps.
- To elucidate the distinct mechanisms of 5 eal-ASO and 3 eal-ASO in RNA splicing inhibition.
- To provide a tool for ASO design and discovery of splicing modulators.
Main Methods:
- Padlock probe-based isothermal amplification assay.
- Quantification of specific products across different RNA splicing steps.
- Distinguishing inhibition of the first and second transesterification steps.
Main Results:
- The assay successfully quantified splicing products with high sensitivity.
- 5 eal-ASO was shown to inhibit the first step of RNA splicing.
- 3 eal-ASO was demonstrated to inhibit the second step of RNA splicing.
Conclusions:
- The developed assay enables precise analysis of RNA splicing efficiency.
- The study clarifies the distinct inhibitory mechanisms of 5 eal-ASO and 3 eal-ASO.
- This method supports the development of targeted ASO therapeutics and novel splicing modulators.
